取之不竭 发表于 2025-3-23 12:37:44

http://reply.papertrans.cn/2/113/11205/11205-11.png

Blatant 发表于 2025-3-23 17:12:29

http://reply.papertrans.cn/2/113/11205/11205-12.png

锯齿状 发表于 2025-3-23 22:01:24

Submitted on: 24 October 2020.
Revised on: 27 November 2020.
Accepted on: 17 January 2021.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

SUGAR 发表于 2025-3-23 22:20:32

http://reply.papertrans.cn/2/113/11205/11205-14.png

生命 发表于 2025-3-24 03:12:58

http://reply.papertrans.cn/2/113/11205/11205-15.png

defendant 发表于 2025-3-24 07:20:30

Submitted on: 18 August 2012.
Revised on: 18 September 2012.
Accepted on: 06 October 2012.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

anaerobic 发表于 2025-3-24 13:34:07

Submitted on: 11 June 2003.
Revised on: 13 August 2003.
Accepted on: 20 September 2003.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

欢乐中国 发表于 2025-3-24 16:17:20

Submitted on: 18 September 1998.
Revised on: 18 December 1998.
Accepted on: 20 January 1999.

___________________HEMATOLOGICAL ONCOLOGY---WILEY

echnic 发表于 2025-3-24 20:42:20

http://reply.papertrans.cn/2/113/11205/11205-19.png

Astigmatism 发表于 2025-3-25 00:42:14

Submitted on: 09 February 2001.
Revised on: 31 May 2001.
Accepted on: 11 July 2001.

___________________HEMATOLOGICAL ONCOLOGY---WILEY
页: 1 [2] 3 4
查看完整版本: SCIE期刊HEMATOLOGICAL ONCOLOGY 2024/2025影响因子:3.393 (HEMATOL ONCOL) (0278-0232). (HEMATOLOGY)(血液学)Science Citation Index E